China NT Pharma Group Co., Ltd. (1011) Financial Statements

2 Followers

China NT Pharma Group Co., Ltd. Financial Overview

China NT Pharma Group Co., Ltd.'s market cap is currently HK$578.89M. The company's EPS TTM is HK$-0.0435; its P/E ratio is -17.45; China NT Pharma Group Co., Ltd. is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 24.16M	¥ 37.96M	¥ 7.37M	¥ 207.09M	¥ 226.70M
Gross Profit	¥ 9.61M	¥ 5.26M	¥ 7.37M	¥ 125.29M	¥ 145.46M
Operating Income	¥ -12.36M	¥ -13.23M	¥ -56.21M	¥ -26.54M	¥ -99.43M
EBITDA	¥ -12.32M	¥ -8.65M	¥ 1.33M	¥ 10.39M	¥ -17.78M
Net Income	¥ -26.04M	¥ -53.36M	¥ -143.59M	¥ -66.41M	¥ -149.54M
Balance Sheet
Cash & Short-Term Investments	¥ 7.22M	¥ 9.62M	¥ 1.52M	¥ 5.93M	¥ 9.44M
Total Assets	¥ 347.50M	¥ 334.07M	¥ 329.12M	¥ 1.01B	¥ 955.36M
Total Debt	¥ 316.83M	¥ 375.95M	¥ 344.94M	¥ 826.45M	¥ 832.11M
Net Debt	¥ 309.61M	¥ 366.33M	¥ 343.42M	¥ 820.52M	¥ 822.67M
Total Liabilities	¥ 621.45M	¥ 733.18M	¥ 668.69M	¥ 1.25B	¥ 1.17B
Stockholders' Equity	¥ -273.74M	¥ -399.11M	¥ -339.56M	¥ -241.66M	¥ -211.38M
Cash Flow
Free Cash Flow	¥ -24.71M	¥ -9.24M	¥ 37.58M	¥ 31.72M	¥ -135.42M
Operating Cash Flow	¥ -24.55M	¥ -9.07M	¥ 50.48M	¥ 36.21M	¥ -134.78M
Investing Cash Flow	¥ -154.88K	¥ -189.00K	¥ -22.14M	¥ 4.53M	¥ 257.81M
Financing Cash Flow	¥ 24.05M	¥ 12.65M	¥ -28.97M	¥ -46.68M	¥ -124.80M

Currency in CNY

China NT Pharma Group Co., Ltd. Earnings and Revenue History

Income Statement >

China NT Pharma Group Co., Ltd. Debt to Assets

Balance Sheet >

China NT Pharma Group Co., Ltd. Cash Flow

Cash Flow >

China NT Pharma Group Co., Ltd. Forecast EPS vs Actual EPS

Earnings >